Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

IODINE CTR SRT 300MG 300 MCG — DIN 00540129

IODINE (POTASSIUM IODIDE) : 300 MCG · BIOENERGY INC. · TABLET (EXTENDED-RELEASE) · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is IODINE CTR SRT 300MG?

IODINE CTR SRT 300MG 300 MCG contains IODINE (POTASSIUM IODIDE) : 300 MCG. It is listed in the Health Canada Drug Product Database under DIN 00540129, held by BIOENERGY INC., supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Jun-1998. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

How much does Iodine Therapy cost around the world?

Iodine Therapy is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Greeceproducer price (ex-factory)1414EUR███.██
South Africasingle exit price28ZAR███.██
United Statesacquisition12USD███.██
Saudi Arabiapublic11SAR███.██

25 pack listings across 18 brand entries and 4 price bases, refreshed 03 Sep 2026. Ranges span every Iodine Therapy pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.

Is there a generic Iodine Therapy in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

8 holders have a Canadian DIN containing Iodine Therapy, across 9 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
DESBERGERS LTÉE, DIVISION OF TECHNILAB INC.20IODAMINOL TAB 10MG, IODAMINOL TAB 30MGNo marketed DIN
BIOENERGY INC.10IODINE CTR SRT 300MGNo marketed DIN
CARTER-HORNER CORP.10THYROBLOCK TAB 130MGNo marketed DIN
HALL LABORATORIES, LTD.10KELP TABLETS 150MCGNo marketed DIN
NION CORP10IODIN RATION TAB 0.15MGNo marketed DIN
SABEX INC 110 De Lauzon Street Boucherville Quebec Canada J4B 1E610SODIUM IODIDE INJ 100MG/MLNo marketed DIN
SEROYAL INTERNATIONAL INC.10LIQUID IODINENo marketed DIN
THERAPEUTIC FOODS CO.10IODINE TAB 3MGNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label300 MCG
Dosage formTABLET (EXTENDED-RELEASE)
RouteORAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceIodine Therapy
ATC codeH03CA
AHFS class88:29.00* ; See footnote
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00540129
DIN (unpadded, as printed on some documents)540129
Brand nameIODINE CTR SRT 300MG
Generic / active ingredientIODINE (POTASSIUM IODIDE) : 300 MCG
Market authorization holderBIOENERGY INC.
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeH03CA
ATC anatomical main groupH — Systemic hormonal preparations
ATC therapeutic subgroupH03CA
Current statusCANCELLED POST MARKET
Status date03-Jun-1998
Original market date1979-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 9 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
IODAMINOL TAB 10MG10 MGTABLETDESBERGERS LTÉE, DIVISION OF TECHNILAB INC.CANCELLED POST MARKET00086339
IODAMINOL TAB 30MG30 MGTABLETDESBERGERS LTÉE, DIVISION OF TECHNILAB INC.CANCELLED POST MARKET00242799
IODIN RATION TAB 0.15MG.15 MGTABLETNION CORPCANCELLED POST MARKET00399183
IODINE TAB 3MG3 MGTABLETTHERAPEUTIC FOODS CO.CANCELLED POST MARKET00190829
KELP TABLETS 150MCG150 MCGTABLETHALL LABORATORIES, LTD.CANCELLED POST MARKET00534617
LIQUID IODINE.15 MG / .04 MLLIQUIDSEROYAL INTERNATIONAL INC.CANCELLED POST MARKET00554642
SODIUM IODIDE INJ 100MG/MLStrengthLiquidSABEX INC 110 De Lauzon Street Boucherville Quebec Canada J4B 1E6CANCELLED POST MARKET00807680
THYROBLOCK TAB 130MG130 MGTABLETCARTER-HORNER CORP.CANCELLED POST MARKET00518077

2 · Same class — other molecules in ATC H03CA

MoleculeCanadian brandsDINsMarketedSourceable
Iodine TherapyIODAMINOL TAB 10MG · IODAMINOL TAB 30MG · IODIN RATION TAB 0.15MG · IODINE CTR SRT 300MG · +5 more90Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is IODINE CTR SRT 300MG called?

The same molecule, Iodine Therapy, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
CENTRUM SILVER TABLETSLatinSaudi Arabia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00540129. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.